References
Anshu A, Price MO, Price FW Jr (2012) Risk of corneal transplant rejection significantly reduced with Descemet’s membrane endothelial keratoplasty. Ophthalmology 119:536–540
Cursiefen C (2013) Descemet membrane endothelial keratoplasty: the taming of the shrew. JAMA Ophthalmol 131:88–89
Melles GR, Ong TS, Ververs B, van der Wees J (2006) Descemet membrane endothelial keratoplasty (DMEK). Cornea 25:987–990
Hos D, Tuac O, Schaub F et al (2017) Incidence and clinical course of immune reactions after Descemet membrane endothelial keratoplasty - retrospective analysis of 1000 consecutive eyes. Ophthalmology 124(4):512–518
Funding
This study received funding from German Research Foundation (DFG) FOR2240 “(Lymph)-angiogenesis and Cellular Immunity in Inflammatory Diseases of the Eye” (CC, DH www.for2240.de); EU COST BM1302 (BOB, CC, DH); EU Horizon 2020 ARREST BLINDNESS (CC).
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
The authors declare that they have no conflict of interest.
Ethical approval
All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.
Informed consent
For this type of study formal consent is not required.
Additional information
Publisher’s note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Schaub, F., Bachmann, B.O., Cursiefen, C. et al. Midterm follow-up of immune reactions after Descemet membrane endothelial keratoplasty (DMEK). Graefes Arch Clin Exp Ophthalmol 257, 1811–1812 (2019). https://doi.org/10.1007/s00417-019-04357-4
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00417-019-04357-4